Overview Fundamentals API Earnings EOD API Sample Code Pricing

NRX Pharmaceuticals Inc (NRXP NASDAQ) stock market data APIs

$2.39 -0.09(-3.6%) as of July 12, 2024
Price chart is built with Anychart

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned food and drug administration-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior. The company has a partnership with Alvogen Inc. and Lotus Pharmaceutical Company; development and manufacturing agreement with Nephron Pharmaceuticals, Inc. and Alcami; license agreement with Apkarian Technologies; development and license agreement with Glytech; license agreement with Sarah Herzog Memorial Hospital. The company was founded in 2015 and is based in Wilmington, Delaware.

NRX Pharmaceuticals Inc Financial Data Overview

2.48
2.39
-
2.55
2.38
1.9-7.33
26 537 K
0.4769
10 701 K
0
-0.74
1.261
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NRXP',
Type: 'Common Stock',
Name: 'NRX Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00JCWDN63',
ISIN: NULL,
CUSIP: NULL,
CIK: '1719406',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2017-12-04',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

NRX Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -24 145 000
  • Earnings Per Share 5.2
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get NRX Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-05-14
  • EPS/Forecast -0.55

Get NRX Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com